Louisiana State Employees Retirement System Arcus Biosciences, Inc. Transaction History
Louisiana State Employees Retirement System
- $5.11 Billion
- Q2 2024
A detailed history of Louisiana State Employees Retirement System transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Louisiana State Employees Retirement System holds 27,500 shares of RCUS stock, worth $424,050. This represents 0.01% of its overall portfolio holdings.
Number of Shares
27,500
Previous 26,800
2.61%
Holding current value
$424,050
Previous $505,000
17.23%
% of portfolio
0.01%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding RCUS
# of Institutions
207Shares Held
49MCall Options Held
173KPut Options Held
151K-
Black Rock Inc. New York, NY9.76MShares$151 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.26MShares$81.1 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA4.25MShares$65.5 Million0.65% of portfolio
-
State Street Corp Boston, MA3.06MShares$47.1 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.83MShares$28.3 Million0.08% of portfolio
About Arcus Biosciences, Inc.
- Ticker RCUS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 72,160,000
- Market Cap $1.11B
- Description
- Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...